TROG Cancer Research
Members Login   CQMS Login

 

TROG 2021 Virtual Annual Scientific Meeting

23 – 24 March 2021

 

Register now for the 2021 Virtual Annual Scientific Meeting

 

 

The TROG ASM Organising Committee together with the TROG Board of Directors have been monitoring the COVID-19 situation closely and due to ongoing risks, travel and gathering restrictions, a decision has been made to proceed with a virtual ASM in 2021.

 

The Virtual ASM format will provide delegates from around the world with an exciting opportunity to share educational and scientific content, without the need to meet face-to-face. A highly interactive program has been developed to include engaging keynote presentations and panel sessions, with topical content and networking opportunities, showcasing both national and international presenters. The full and extensive program will include two days of scientific sessions showcasing radiation oncology clinical trials, discussion of new trial concepts, future research directions and technological advancements.

 

The Radiation Oncology Trainee SMART Workshop will also be hosted virtually as a pre-ASM event on 22 March 2021 and the Technical Research Workshop (TRW) will take place during the ASM, on the afternoon of 23 March 2021.

 

The Organising Committee looks forward to welcoming delegates virtually from across the globe.

 

Dr Renee Finnigan

TROG 2021 ASM Co-Convenor

 

Dr John Shakeshaft

TROG 2021 ASM Co-Convenor

 

 

 

 

Become a TROG member and join our community of over 1,000 health professionals.


Latest News

  • 06 Apr 2021

    Dear TROG Members, Per correspondence sent out on 17 March, there are two (2) vacant positions on the TROG Board, one for an Elected Full Member Director (New Zealand) and one for President. Nominations were accepted until close of business 30 March 2021. The nominations received are as follows ...

  • 10 Dec 2020

    An international study (BIG 3-07/TROG 07.01) shows that after breast conserving surgery, higher radiation doses to the part of the breast where the DCIS was found, in addition to radiotherapy of the whole breast, significantly reduced its risk of returning in patients with higher-risk DCIS.

  • 15 May 2020

    The diagnosis of ductal carcinoma in situ (DCIS) of the breast has increased substantially due to mammographic screening, and now accounts for 25 per cent of screen-detected breast cancer. Over 1,600 women are diagnosed with DCIS in Australia every year. However, unlike invasive breast cancer, there are limited knowledge and experience for patients and clinicians to draw on when this now common diagnosis of DCIS is made.

  • 15 Apr 2020

    Prostate cancer is one of the most common cancers amongst men, with one in six men diagnosed before their 85th birthday (Cancer Australia). In fact, in 2019 alone over 19,000 men in Australia were diagnosed with prostate cancer.

  • 06 Apr 2020

    p style="text-align: center;">_ src="/sitefiles/trogcomau/trog_team_2020.jpg" style="height: 333px; width: 500px;" />   covid-19 and the regulations around social distancing has affected an increasing number of events across australia, including the yearly gathering of radiation...

  • 01 Apr 2020

    The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we operate clinical trials – those that are underway, set t...

  • 15 Jan 2020

    _ src="/sitefiles/trogcomau/fbp_0378_large.jpg" /> new research by the university of new south wales (unsw), presented at the clinical oncology society of australia’s (cosa) annual scientific meeting (asm) found that increased use of radiation therapy for prostate cancer patients c...

  • 13 Sep 2019

    trog cancer research will work with clinicians at townsville hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new mri linac technology to benefit cancer patients. img src="/sitefiles/trogcomau/tro_trog_cancer_resear...

  • 09 Sep 2019

    TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.  The workshop facilitated by Ms Alison Evans, Hea...

  • 03 Sep 2019

    trog cancer research are proud to announce that we have two new additions to the trog cancer research board of directors. joining our team is professor annette haworth and denis byron. appointed as a non-radiation oncology director, annette is an accredited medical physicist wh...